Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
R&D Expense Growth Trend
Above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
31.26%
↑ 93% above average
Average (9y)
16.22%
Historical baseline
Range
High:31.26%
Low:-0.92%
CAGR
+1.7%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 31.26% |
| 2023 | 30.45% |
| 2022 | 16.56% |
| 2021 | 4.91% |
| 2020 | 11.58% |
| 2019 | 9.90% |
| 2018 | 5.61% |
| 2017 | -0.92% |
| 2016 | 26.00% |
| 2015 | 26.83% |